Literature DB >> 22001589

Transfusion of fresh but not old stored blood reduces infarct size and improves cardiac function after acute myocardial infarction in anemic rats*.

Houxiang Hu1, Anargyros Xenocostas, Nicolas Chin-Yee, Xiangru Lu, Ian Chin-Yee, Qingping Feng.   

Abstract

OBJECTIVES: We recently demonstrated that transfusion of fresh blood to 100 g/L hemoglobin in anemic animals offers cardioprotection after acute myocardial infarction. The objective of this study was to compare the cardioprotective effects of fresh vs. stored blood when transfused in anemic rats after acute myocardial infarction. STUDY
DESIGN: Randomized animal study.
SETTING: University laboratory.
SUBJECTS: Male Sprague-Dawley rats weighing 200-300 g. INTERVENTION: Myocardial infarction was induced by coronary artery ligation in 49 male Sprague-Dawley rats weighing 200-300 g, 38 of which were anemic (80-90 g/L) and 11 with normal hemoglobin levels. Anemic animals were randomized to receive fresh blood (within 4 hrs), stored blood (7 days), or no transfusion immediately after myocardial infarction.
MEASUREMENTS AND MAIN RESULTS: At 24 hrs after myocardial infarction, cardiac function, infarct size, and apoptosis were determined. Erythrocyte ATP, 2,3-DPG, hemoglobin, and free hemoglobin levels in the supernatant were determined. Transfusion with fresh but not stored blood significantly decreased infarct size and myocardial apoptosis in anemic rats when compared to anemic animals not undergoing transfusion. Cardiac function and survival were significantly improved in the anemic animals undergoing fresh blood transfusion compared to control anemic animals. Analysis of stored red blood cells showed reductions of intracellular ATP and 2,3-DPG levels and free hemoglobin was increased in the supernatant.
CONCLUSIONS: The prolonged storage of blood negates the beneficial effects of fresh blood transfusion, which include reductions in infarct size and myocardial apoptosis, and improvements in cardiac function and short-term survival after acute myocardial infarction in this animal model.

Entities:  

Mesh:

Year:  2012        PMID: 22001589     DOI: 10.1097/CCM.0b013e3182376e84

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Established and theoretical factors to consider in assessing the red cell storage lesion.

Authors:  James C Zimring
Journal:  Blood       Date:  2015-02-04       Impact factor: 22.113

2.  Age of Red Cells for Transfusion and Outcomes in Critically Ill Patients: A Meta-Analysis.

Authors:  Wei Zhang; Kun Yu; Ni Chen; Miao Chen
Journal:  Transfus Med Hemother       Date:  2019-03-28       Impact factor: 3.747

3.  Lin28a protects against hypoxia/reoxygenation induced cardiomyocytes apoptosis by alleviating mitochondrial dysfunction under high glucose/high fat conditions.

Authors:  Mingming Zhang; Xiaolin Niu; Jianqiang Hu; Yuan Yuan; Shuhong Sun; Jiaxing Wang; Wenjun Yu; Chen Wang; Dongdong Sun; Haichang Wang
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

4.  Fresh red blood cells transfusion protects against aluminum phosphide-induced metabolic acidosis and mortality in rats.

Authors:  Nastaran Rahimi; Amir Hossein Abdolghaffari; Alireza Partoazar; Nina Javadian; Tara Dehpour; Ali R Mani; Ahmad R Dehpour
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

5.  Irisin protects cardiomyocytes against hypoxia/reoxygenation injury via attenuating AMPK mediated endoplasmic reticulum stress.

Authors:  Rongchuan Yue; Mingming Lv; Meide Lan; Zaiyong Zheng; Xin Tan; Xuemei Zhao; Yulong Zhang; Jun Pu; Lei Xu; Houxiang Hu
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

6.  Lycopene protects against hypoxia/reoxygenation-induced apoptosis by preventing mitochondrial dysfunction in primary neonatal mouse cardiomyocytes.

Authors:  Rongchuan Yue; Houxiang Hu; Kai Hang Yiu; Tao Luo; Zhou Zhou; Lei Xu; Shuang Zhang; Ke Li; Zhengping Yu
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.